Ryan Specialty Holdings heads into the final stretch of Q2 with a striking contradiction at its core: insiders spent the past month buying aggressively into weakness, while short sellers have been rebuilding positions into the subsequent rally.
The insider signal is the most compelling data point of the past four weeks. Founder and Executive Chairman Patrick Ryan led the charge on June 5, purchasing 120,000 shares at roughly $32.50 — a $3.9 million commitment that stands as a clear statement of conviction near the stock's recent lows. He was far from alone. The CFO picked up 6,300 shares the same week. Two directors added shares across June 10 and June 12. In total, net insider buying over the past 90 days reached approximately 142,000 shares worth $4.6 million. That kind of coordinated buying from across the C-suite and board — not just one executive — is worth marking.
Short sellers, however, have been moving in the opposite direction. Short interest climbed sharply in the second half of June, jumping from around 12.8 million shares to over 14.3 million — an 11.6% weekly rise — pushing shorts to 11.1% of the free float. That is an elevated reading for a specialty insurance broker. The borrow market remains relaxed despite the positioning shift: cost to borrow is just 0.76%, and availability has actually loosened over the week from a tight 87.7% back to 101.5%, suggesting lenders have replenished supply and the incremental shorts are finding shares without difficulty. Days to cover sits at 5.1 days per the latest FINRA settlement data, meaning any sustained reversal would take time to unwind. The tension between insider conviction and short-seller skepticism — both active simultaneously — is the defining feature of the current setup.
Options traders have taken a sharply more bullish tilt than usual. The put/call ratio has collapsed to 0.58, well below its 20-day average near 1.42 and roughly 1.35 standard deviations below the mean. As recently as late May the ratio was running above 2.0; that rotation from extreme put-loading to call-dominated flow coincides almost exactly with the stock's 18.6% one-month rally to $37.76. The short score from ORTEX has also been climbing, reaching 70.5 — its highest reading in the tracked period — reflecting the combination of elevated short interest and tightening positioning metrics. Together, positioning looks split: options traders are chasing upside, while shorts have not yet capitulated.
The Street's read is mixed but not hostile. Goldman Sachs raised its price target on July 1 from $35 to $40 while keeping a Neutral rating — a partial retracement from its downgrade in early June, when it cut the stock from Buy to Neutral and trimmed the target to $35 from $42. UBS remains at Buy with a $52 target. Morgan Stanley holds Overweight at $39. The consensus mean target is $43.29, implying roughly 15% upside from current levels, though the Goldman Neutral and the bear case — centred on margin pressure, a cautious 2026 organic growth outlook, and dilution risk from a recent option grant — keep a ceiling on re-rating momentum. The EPS surprise factor score of 13 and 90-day EPS momentum rank of just 5 signal that estimate revisions remain a headwind. The dividend score at 78 provides some floor support, but valuation is not cheap: the stock trades at 16x trailing earnings and 6.2x book, up roughly one point on P/E over the past month.
The stock's last earnings reaction is a data point worth holding onto. When RYAN reported on April 30, the stock fell 12.6% the next day and was down 10.1% five days later — the softest post-earnings reaction in the available history. The next print is scheduled for July 30. With shorts at 11% of float, insider buying clustered near the recent lows, options skewed bullishly, and a mixed analyst picture, the July 30 report arrives as a genuine inflection point — the question is whether the organic growth trajectory and margin guidance can bridge the gap between insider conviction and short-seller skepticism. Peers BRO and AJG both posted solid weeks — up 6.2% and 6.4% respectively — suggesting the sector bid is real, even as RYAN's own session on June 30 retreated 3.5%.
What to watch next is whether short interest continues to build through the pre-earnings period, and whether the borrow market tightens back below the 100% availability threshold as July 30 approaches.
See the live data behind this article on ORTEX.
Open RYAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
